Natural killer cells have been arbitrarily defined using a number of different phenotypic and functional criteria. We asked Lorenzo Moretta if we have truly discovered the core identity of this critical player in eliciting immune responses.
References
Trinchieri G. Adv. Immunol. 47, 176–187 (1989).
Moretta, L., Ciccone, E., Mingari, M. C., Biassoni, R. & Moretta, A. Adv. Immunol. 55, 341–380 (1994).
Kim, S., Iizuka, K., Aguila, H. L., Weissman, I. L. & Yokoyama, W. M. Proc. Natl Acad. Sci. USA 97, 2731–2736 (2000).
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. Annu. Rev. Immunol. 17, 189–220 (1999).
Ljunggren, H. G. & Karre, K. Immunol. Today, 11, 237–244 (1990).
Yokoyama, W. M. & Seaman, W. E. Annu. Rev. Immunol. 11, 613 (1993).
Moretta, A. et al. Annu. Rev. Immunol. 14, 619–648 (1996).
Lanier, L. L. Annu. Rev. Immunol. 16, 359–393 (1998)
Moretta, A. et al. Annu. Rev. Immunol. 19, 197–223 (2001).
Diefenbach, A. & Raulet, D. H. Immunol. Rev. 181, 170–184 (2001).
Sutherland, C. L., Chalupny, N. J & Cosman, D. Immunol. Rev. 181, 185–192 (2001).
Parolini, S. et al. J. Exp. Med. 192, 337–346 (2000).
Bottino, C. et al. J. Exp. Med. 194, 235–246 (2001).
Khakoo, S. I. et al. Immunity 12, 687–698 (2000).
De Maria, A. et al. Eur. J. Immunol. 31, 3546–3556 (2002).
Mandelboim, O. et al. Nature 409,1055–1060 (2001).
Arnon, T. I. et al. Eur. J. Immunol. 9, 2680–2689 (2001).
Ruggeri, L., Capanni, M., Martelli, M. F. & Velardi, A. Curr. Opin. Hematol. 6, 355–359 (2001).
Acknowledgements
Supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro, Istituto Superiore di Sanità, Consiglio Nazionale delle Ricerche, Progetto Finalizzato Biotecnologie, MURST-CNR 5% CNR Biotechnology program 95/95 and Telethon-Italy (grant number E.0892).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moretta, A., Bottino, C., Mingari, M. et al. What is a natural killer cell?. Nat Immunol 3, 6–8 (2002). https://doi.org/10.1038/ni0102-6
Issue Date:
DOI: https://doi.org/10.1038/ni0102-6
- Springer Nature America, Inc.
This article is cited by
-
Natural killer cell therapies
Nature (2024)
-
Natural killer cells and acute myeloid leukemia: promises and challenges
Cancer Immunology, Immunotherapy (2022)
-
TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
BMC Immunology (2021)
-
Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage
Scientific Reports (2020)
-
Contributions of natural killer cells to the immune response against Plasmodium
Malaria Journal (2019)